The scoreboard

Filing nothing today — it's math, not reluctance. Book β0.9106 pinned on the 0.90 floor. Funded from SPY (β1.0), no add clears unless its beta is well north of 1.0. Live tests, all vetoed on the floor:

• CSCO 2.5%, SPY→64.2% → β0.898 (0.2bp under)
• CSCO 2.2% + deeper SPY trim → β0.887
• CSCO + UNP → β0.877

Off-the-highs quality fails the floor solo: MMC 0.752, ADP 0.841, AMGN 0.403, LMT 0.113, RTX 0.298, DE 0.897. Beta-≥1.0 names are rich/at highs: CAT 1.565 @43x, TXN 1.31 @49.8x — won't chase.

Two names print TODAY (freeze): HON (Margaret #23, the winner — 13.7x fwd, 4.1% yld/23% payout, β0.93, breakup catalyst) and UNP (my rail add). UNP also live $292.56, +9.4%/window, ~3.5% off high — double-disqualified.

Correction for the record: CSCO is NOT at its high — live $112.21, -3.7%/window, ~14% off the $129.88 high (EODHD summary was stale). Mid-range, reports 08-12 clear. Cleanest beta-additive quality name we have on price+fundamentals; only the floor math blocks it today.

Sequencing to unblock: seat HON next session post-print (count 15→16, cash-flow-today, β0.93 doesn't drag) — that rebuilds count and gives the beta average room; THEN CSCO clears. Don't breach the floor to rush it. Backing Margaret's no-forced-buy.

The box is a vise on my lane. Cash-flow-today + beta ≥0.90 + no-chasing-highs eliminates most of my bench: XOM 0.18, BMY 0.26, GILD 0.33, ADP 0.84, TJX 0.62, CMCSA 0.66 — all sub-0.90, DOA solo against the floor. The names that carry beta are either rich or reporting.

HON is the fundamental winner — thesis #23, conv 4. FY25 10-K (SEC XBRL, period-end 2025-12-31): rev $37.4B, op inc $8.13B (21.7% margin, UP YoY from $7.67B), OCF $6.41B, EPS $7.36, $12.5B cash. 4.1% fwd yield on a 23% payout — cash-flow-today, covered many times. Cheap-end: 13.7x fwd / 15.9x EV/EBITDA, ~10% off the $258.86 52w high ($232.99 last), above 50d/200d. Beta 0.93 CLEARS the floor. Mid three-way breakup catalyst. Ignore EODHD's -41.9% EPS-YoY — split/spin artifact; the filing shows op income rising.

Why not today: HON reports Q2 07-23 — today. Opening into the print trips the post-earnings sizing freeze and repeats the AAPL mistake we killed 4-0 on 07-20. TABLE for the NEXT session, post-print, ~2.5% from SPY — fixes count 15→16, adds cash-flow-today, funded from SPY, doesn't drag beta. STOP: op margin <17%, OCF <$5B, breakup delayed/cancelled, or -15% rel.

Rejected on discipline: TXN 49.8x/38.6x & ADI 56.8x — near highs, won't pay. CSCO beta 1.007 clean & reports 08-12 clear, but 23.6x fwd / 25x EV-EBITDA at its 52w high on AI-networking momentum — chasing the top. QUAL beta 0.90 sits ON the floor (basket drags to 0.9089) and near its own high — thin edge.

I'm not forcing a weak name into the count today. The floor is what's killing my value bench. Bring HON clean next session and it fixes count, cash, and the active gap in one motion. Daniel — flag HON for the next agenda, post-print.

Regime (Priya's, tighter): 10yr 4.63, reals 2.37 — 4th-week cycle high, refuses to ease. Duration cap ON: quality / low-vol / cash-flow-today. HY OAS 2.69 complacent, VIX 16.6 benign — low-vol tilt is cheap. WTI $70→$84 in two weeks: energy hedge vindicated, hold XOM.

The box (binds before we spend): cash 1.78% sub-floor; count 15 vs 18 min-holdings (2 under — must ADD names); beta 0.911 on the 0.90 floor (nothing added can pull it lower — kills solo low-beta adds and net closes).

Target gross ~98% — spend cash to floor-plus.

Sectors: SPY 65.2% is the albatross (-17.3bps active) — grind into active names, but every recycle must ADD a holding, not swap 1-for-1. Lean OUT of Financials adds — best sector since inception (+39.8bps active) but +6.3pp overweight bled -12.5bps LAST meeting (SPGI -13.3, V -9.4). Engine (V/GS/SPGI) stays; no new weight there. Close TMT (-8.3pp underweight, carries the beta we need). Watch Comm Svcs / GOOGL (-8.9 active).

Factor sponsored: quality + low-vol + cash-flow-today, energy intact.

Ask the room: bring 2+ new quality names, beta ≥0.90 each, funded from SPY — fixes count, cash, and the active gap in one motion. Solo low-beta adds are DOA vs the floor.

#90 — CME close + HD 2.5% open, one inseparable pair. AAPL as the recycle leg is done — voted down 4-0 (52w high, 40x, 07-30 print inside the freeze) and vetoed on a hard risk limit. HD is the strictly cleaner leg for the identical job.

Why CME goes: β0.26 dead money, -16bps active since inception (second-worst detractor behind SPY), no live thesis. Reports 07-22 inside the freeze — exit before the print. Solo close trips the 18-min-holdings floor at 13; paired with HD, count holds 14.

Why HD (2.5%): ~19% off the $418 52w high, between 50d/200d — trough of a rate-sensitive cyclical soft patch, not a franchise crack. FY25 (10-K, SEC XBRL): rev $164.7B, ~12.7% op margin, $16.3B OCF, 2.75% aristocrat. Full clip vs AAPL's 2.3% fresh-high starter. Earnings 08-18, clear of freeze.

GATE (live basket, zero breaches): β0.9101→0.9039 (holds 0.90 floor), cash 1.74→4.09%, Cons Disc 7.4→9.6% (closes worst active underweight), Financials 19.7→17.0%, count 14, top-5 76.1%.

STOP (HD): comps structurally negative, op margin <11%, OCF <$13B, or -15% rel. Catalyst: CME's 07-22 print — we exit ahead of it. To the vote.

#86 AAPL 2.3% open — tabled, not filed. It's a valid CME-recycle partner and clears the gate zero breaches (β0.9101→0.9055, cash→4.09%, closes most of the -7.5pp TMT underweight, count holds 14). But AAPL last close $333.74 is at the $334.99 52w high, +12.6% in a month, 40x trailing / 35x fwd, into a 07-30 print 10 days out. That's chasing the top into an event. On 07-16 I sized AAPL 2.3% for exactly this caveat — ten days later it's higher and closer to the catalyst. I won't open it here.

Re-filing the swap the room already voted 4-0: CME close + HD 2.5%, one inseparable pair. The min-holdings veto (13 vs 18) killed CME's close, not the swap logic — pairing one-for-one holds the count at 14. HD is the strictly cleaner leg for the identical job: ~19% off its high, trough of a rate-sensitive cyclical soft patch, reports 08-18 clear of the freeze. Basket clears zero breaches: β0.9101→0.9039 (holds 0.90 floor), cash 1.74→4.09%, Cons Disc 7.4→9.6% (closes the worst active-bleeding underweight), Financials 19.7→17.0%, top-5 76.1%.

STOP (HD): comps structurally negative, op margin <11%, OCF <$13B, or -15% rel. Catalyst now: CME's 07-22 print — we exit ahead of it. To the vote.

Filing CME full close + HD 2.5% open as one inseparable pair. Theses #22 (CME retire) + #21 (HD).

This is the recycle I've owed since 06-18. It kept getting blocked because closing CME solo drops us to 13 vs the 18-name min-holdings floor. Pairing it one-for-one with HD fixes that: CME out, HD in, count holds at 14, no floor trip. And CME reports 07-22 — I want out before the print, not resizing into it under the freeze. Today is the window.

GATE (live check_basket_risk): clears, zero breaches.

• Beta 0.9101 → 0.9039 — holds the 0.90 floor (HD β0.951 lifts; CME β0.26 leaving is the tighter constraint, still clears with a whisker).
• Cash 1.74% → 4.09% — rebuilds the SGOV residual well inside [2%,10%].
• Consumer Discretionary 7.4% → 9.6% — closes most of our -3.6pp-most-underweight, worst active-bleeding sector.
• Financials 19.7% → 17.0% — trims the +6.7pp overweight; V/GS/SPGI engine untouched.
• Count 14, top-5 78.6% → 76.1%.

Why CME goes (thesis #22, conv 1): β0.26 dead money — -6.43% since entry, -16.1bps total / -12.5bps active since inception, second-worst detractor behind only SPY. Fine business, no live thesis. Q2 07-22 forces it.

Why HD (thesis #21, conv 4, FY25 10-K SEC XBRL, period-end 2026-02-01): rev $164.7B, op inc $20.9B (~12.7% margin), NI $14.16B, dil EPS $14.23, OCF $16.3B, 2.75% aristocrat. Equity thin by design (buybacks) so ROE screens >100% — honest read is ~13% op margin + $16B+ OCF every year. Fwd PE 22.8x, EV/EBITDA 15.9x — quality, not cheap-end, so conv 4. Why now: ~$339 vs $418 52w high — ~19% drawdown, between 50d ($326) and 200d ($352). FY25 EPS -4.6% YoY is a rate-sensitive big-ticket cyclical soft patch, NOT a franchise crack. Buying the trough of a good business. Earnings 08-18, outside freeze. STOP: comps structurally negative, op margin <~11%, OCF <~$13B, or -15% rel.

Separately — GS, reaffirming hold-not-chase. My top since-inception name (+11.1bps active), Q2 gapped it on a 45% beat. A resize clears the gate but I won't chase the gap-up — hold GS, don't add at the high. Same discipline as 07-16.

Daniel, Priya, Iris — your names. Then to the vote.